Natanael Leitão

Founder @ YLive

About

Biologist with a PhD in Microbiology and Immunology and experience in R&D, entrepreneurship, and venture capital. For over seven years, I’ve been leading YLive, an agtech company developing biotechnology solutions for precision livestock farming. My work focuses on integrating AI and biological data to drive more efficient, sustainable, and evidence-based animal production. Venture Partner at Zentynel Frontier Investments, a biotech-focused venture capital fund supporting startups across Latin America, with investments in Brazil, Uruguay, Argentina, Mexico, Colombia, and the United States. I help identify and accelerate high-impact scientific projects in health, agriculture, and environmental sectors. I believe biotechnology is a key driver of transformative innovation in the 21st century and work with the goal of generating lasting, positive impact within local ecosystems.

Country

Brazil

City

São Paulo

Industry

Biotechnology

Skill

Empreendedorismo, Capital de risco, Agronegócios, Biotecnologia, Microbiologia, Biologia celular, Project Management, Business Innovation, Entrepreneurship

Experience

Founder

YLive

2018-5 - Present · 8 yrs 5 mos

Av. Profº Lineu Prestes, 2242, Butantã – Cidade Universitaria – IPEN – São Paulo

A YLive é uma AgTech que oferece soluções para aumentar a saúde e o desempenho animal através da pecuária de precisão. Nossa plataforma realiza a avaliação de sistemas produtivos por meio de uma combinação entre biotecnologia e inteligência artificial, isso nos permite identificar problemas de desempenho zootécnico, bem-estar e sustentabilidade e indicar os melhores produtos veterinários para cada sistema.

Operational Partner

Zentynel Frontier Investments

2024-8 - Present · 2 yrs 2 mos

Zentynel is a venture capital fund specializing in biotechnology, born from the convergence of Fundación Ciencia y Vida and Venturance Alternative Assets. Our mission is to bridge the investment gap in biotechnology projects in Latin America, driving progress from local research and development to global execution and commercialization. We combine our expertise in science and business to lead the fourth industrial revolution, accelerating growth and innovation in biotechnology in the region.